Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice

International Immunopharmacology

Volumn 7, Issue 5, 2007, Pages 687-700

  Pan, Chia Yu ^a   Chao, Tsung Tai ^a   Chen, Jian Chyi ^b   Chen, Jyh Yih ^a   Liu, Wei Chen ^c   Lin, Cheng Hui ^c   Kuo, Ching Ming ^a  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

Anti LPS; Bactericide; Gene expression; Sepsis; Shrimp

Indexed keywords

CYCLOPEPTIDE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SALF 55-76; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CARBOXY TERMINAL SEQUENCE; CELL SWELLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE SEPSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPTIC SHOCK; SHRIMP;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PENAEIDAE; PEPTIDE FRAGMENTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS;

EID: 33947539072     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.01.006     Document Type: Article

References (46)

1. Patrzykat A., and Douglas S.E. Gone gene fishing: how to catch novel marine antimicrobials. Trends Biotechnol 21 (2003) 362-369
2. Iwanaga S., Miyata T., Tokunaga F., and Muta T. Molecular mechanism of hemolymph clotting system in Limulus. Thromb Res 68 (1992) 1-32
3. Shike H., Lauth X., Westerman M.E., Ostland V.E., Carlberg J.M., Van Olst J.C., et al. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem 269 (2002) 2232-2237
4. Chen J.Y., Pan C.Y., and Kuo C.M. Molecular cloning and sequencing of shrimp (Penaeus monodon) penaeidin-5 cDNA. Fish Shellfish Immunol 16 (2004) 665-670
5. Douglas S.E., Gallant J.W., Gong Z., and Hew C. Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum). Dev Comp Immunol 25 (2001) 137-147
6. Bachere E., Gueguen Y., Gonzalez M., de Lorgeril J., Garnier J., and Romestand B. Insights into the anti-microbial defense of marine invertebrates: the penaeid shrimps and the oyster Crassostrea gigas. Immunol Rev 198 (2004) 149-168
7. Lehrer R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11 (1999) 23-27
8. Munoz M., Vandenbulcke F., Saulnier D., and Bachere E. Expression and distribution of penaeidin antimicrobial peptides are regulated by haemocyte reactions in microbial challenged shrimp. Eur J Biochem 269 (2002) 2678-2689
9. Brandin E.R., and Pistole T.G. Presence of microorganisms in hemolymph of the horseshoe crab Limulus polyphemus. Appl Environ Microbiol 49 (1985) 718-720
10. Lynn W.A. Anti-endotoxin therapeutic options for the treatment of sepsis. J Antimicrob Chemother 41 Suppl A (1998) 71-80
11. Tobias P.S., Mathison J., Mintz D., Lee J.D., Kravchenko V., Kato K., et al. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 7 (1992) 239-245
12. Klaerner H.G., Dahlberg P.S., Acton R.D., Battafarano R.J., Uknis M.E., Johnston J.W., et al. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis. J Surg Res 69 (1997) 249-254
13. Hoesel L.M., Gao H., and Ward P.A. New insights into cellular mechanisms during sepsis. Immunol Res 34 (2006) 133-141
14. Karima R., Matsumoto S., Higashi H., and Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5 (1999) 123-132
15. Bochud P.Y., and Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326 (2003) 262-266
16. Huang G.T., Zhang H.B., Kim D., Liu L., and Ganz T. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther 13 (2002) 2017-2025
17. Aketagawa J., Miyata T., Ohtsubo S., Nakamura T., Morita T., Hayashida H., et al. Primary structure of limulus anticoagulant anti-lipopolysaccharide factor. J Biol Chem 261 (1986) 7357-7365
18. Supungul P., Klinbunga S., Pichyangkura R., Jitrapakdee S., Hirono I., Aoki T., et al. Identification of immune-related genes in hemocytes of black tiger shrimp (Penaeus monodon). Mar Biotechnol (NY) 4 (2002) 487-494
19. Somboonwiwat K., Marcos M., Tassanakajon A., Klinbunga S., Aumelas A., Romestand B., et al. Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon. Dev Comp Immunol 29 (2005) 841-851
20. Vallespi M.G., Glaria L.A., Reyes O., Garay H.E., Ferrero J., and Arana M.J. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Clin Diagn Lab Immunol 7 (2000) 669-675
21. Alpert G., Baldwin G., Thompson C., Wainwright N., Novitsky T.J., Gillis Z., et al. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock. J Infect Dis 165 (1992) 494-500
22. Vallespi M.G., Alvarez-Obregon J.C., Rodriguez-Alonso I., Montero T., Garay H., Reyes O., et al. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice. Int Immunopharmacol 3 (2003) 247-256
23. Vallespi M.G., Colas M., Garay H., Reyes O., and Arana M.J. Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in gram-positive sepsis. Int Immunopharmacol 4 (2004) 1343-1351
24. Pristovsek P., Simcic S., Wraber B., and Urleb U. Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor. J Med Chem 48 (2005) 7911-7914
25. Chang I.C., Lee T.H., Yang C.H., Wei Y.Y., Chou F.I., and Hwang P.P. Modulation in morphology and function of gill mitochondria-rich cells in fish acclimated to different environments. Physiol Biochem Zool 74 (2001) 111-119
26. Chen H.M., Chan S.C., Lee J.C., Chang C.C., Murugan M., and Jack R.W. Transmission electron microscopic observations of membrane effects of antibiotic cecropin B on Escherichia coli. Microsc Res Tech 62 (2003) 423-430
27. Chen J.Y., Chen J.C., Huang W.T., Liu C.W., Hui C.F., Chen T.T., et al. Molecular cloning and tissue-specific, developmental-stage-specific, and hormonal regulation of IGFBP3 gene in zebrafish. Mar Biotechnol (NY) 6 (2004) 1-7
28. Andra J., Lamata M., Martinez de Tejada G., Bartels R., Koch M.H., and Brandenburg K. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Biochem Pharmacol 68 (2004) 1297-1307
29. Supungul P., Klinbunga S., Pichyangkura R., Hirono I., Aoki T., and Tassanakajon A. Antimicrobial peptides discovered in the black tiger shrimp Penaeus monodon using the EST approach. Dis Aquat Organ 61 (2004) 123-135
30. Morita T., Ohtsubo S., Nakamura T., Tanaka S., Iwanaga S., Ohashi K., et al. Isolation and biological activities of Limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J Biochem (Tokyo) 97 (1985) 1611-1620
31. Pristovsek P., and Kidric J. The search for molecular determinants of LPS inhibition by proteins and peptides. Curr Top Med Chem 4 (2004) 1185-1201
32. McPhee J.B., and Hancock R.E. Function and therapeutic potential of host defence peptides. J Pept Sci 11 (2005) 677-687
33. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
34. Parker S.J., Hill P.F., Brown D., Kenward C.E., and Watkins P.E. A porcine model of sepsis resulting from the combined insults of hemorrhage and peritonitis. Shock 13 (2000) 291-296
35. Remick D.G., Newcomb D.E., Bolgos G.L., and Call D.R. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13 (2000) 110-116
36. Mygind P.H., Fischer R.L., Schnorr K.M., Hansen M.T., Sonksen C.P., Ludvigsen S., et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437 (2005) 975-980
37. Blahova J., Kralikova K., Krcmery Sr. V., Babalova M., Menkyna R., Glosova L., et al. Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients. J Chemother 16 (2004) 269-272
38. Verhoef J., and Mattsson E. The role of cytokines in gram-positive bacterial shock. Trends Microbiol 3 (1995) 136-140
39. Kox W.J., Volk T., Kox S.N., and Volk H.D. Immunomodulatory therapies in sepsis. Intensive Care Med Suppl 1 (2000) S124-S128
40. Feghali C.A., and Wright T.M. Cytokines in acute and chronic inflammation. Front Biosci 2 (1997) d12-d26
41. Miossec P. Acting on the cytokine balance to control auto-immunity and chronic inflammation. Eur Cytokine Netw 4 (1993) 245-251
42. Ansel K.M., Djuretic I., Tanasa B., and Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24 (2006) 607-656
43. Paus E.J., Willey J., Ridge R.J., Legg C.R., Finkelman M.A., Novitsky T.J., et al. Production of recombinant endotoxin neutralizing protein in Pichia pastoris and methods for its purification. Protein Expr Purif 26 (2002) 202-210
44. Hoebe K., Jiang Z., Tabeta K., Du X., Georgel P., Crozat K., et al. Genetic analysis of innate immunity. Adv Immunol 91 (2006) 175-226
45. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
46. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6 (2005) 565-570